Image

Central Serous Chorioretinopathy and Micropulse Laser Treatment

Central Serous Chorioretinopathy and Micropulse Laser Treatment

Recruiting
18-70 years
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

To evaluate choroidal and choriocapillaris changes in patients with central serous chorioretinopathy, undergone sub threshold micropulse laser treatment, following any improvement with conservative therapy with Acetazolamide and/or Eplerenone

Eligibility

Inclusion Criteria:

  • Diagnosis of central serous chorioretinopathy (CSC) with no response to conservative therapy, consisted in Acetazolamide and Eplerenone after six months.
  • Foveal serous retinal detachment for at least 6 months.
  • Minimum age of 18 years old at the screening time
  • Reading and comprehension skills of informed consent

Exclusion Criteria:

  • Previous retinal treatment for CSC, except for Acetazolamide and Eplerenone
  • No diffuse retinal epitheliopathy
  • Other concomitant ocular diseases, such as age related macular degeneration, diabetic retinopathy, choroidal neovascularization
  • Not controlled glaucoma with eyedrops, or advanced glaucoma
  • Myopia or hypermetropia greater than 6 diopters
  • Opacities of dioptric media
  • Low quality of optical coherence tomography (OCT) and OCT-Angiography scans
  • Low quality images of Fluorescein angiography and indocyanine green angiography
  • No written consensus signed.

Study details
    Central Serous Chorioretinopathy

NCT06346405

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

13 April 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.